TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -4 | -5 | -4 | 11 | -14 | -29 | -8 |
| P | %wins | 0 | 0 | 0 | 100 | 0 | 0 | 17 | |||
| S | %ret | 1 | 1 | 1 | 0 | 0 | -11 | 0 | 0 | 0 | -11 |
| S | %wins | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/21/19 16:45 | 3/20/19 | ADMS | Adamas Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Patni Rajiv | CA | O | Chief Me | S | -19 | 8.00 | 0 | -2 | -11 | 19 | D | ||||||||||||||
3/22/18 17:51 | 3/21/18 | ADMS | Adamas Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Patni Rajiv | CA | O | Chief Me | S | -32 | 25.94 | 0 | -1 | -5 | 22 | D | ||||||||||||||
3/22/17 17:05 | 3/21/17 | ADMS | Adamas Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Patni Rajiv | CA | O | Chief Me | S | -12 | 17.04 | 2 | -1 | -5 | 14 | D | -4 | 24 | -3 | 8 | 7 | -6 | 1 | -1 | 0 | 0 | -11 | |||
5/7/15 17:19 | 5/7/15 | OCRX | Ocera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patni Rajiv | CA | O | Chief De | P | 20 | 3.97 | 1 | 5 | New | 5 | D | -39 | -56 | -37 | -41 | -18 | -6 | -1 | 10 | -4 | -5 | -4 | 11 | -14 | -29 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |